As per the agreement, Knee Creations will use Etex’s patented nanocrystalline calcium phosphate technology in its novel Subchondroplasty procedure.

Etex Corporation president and CEO Brian Ennis said that both the companies have forged a dynamic partnership over the past three years.

"It has been our pleasure to assist Knee Creations in establishing a revolutionary treatment method to address defects associated with chronic bone marrow lesions," Ennis added.